{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:23:42Z","timestamp":1762341822468,"version":"3.37.3"},"reference-count":49,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CER-1503-29191"],"award-info":[{"award-number":["CER-1503-29191"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2022,1,17]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Bronchiectasis is an increasingly common chronic inflammatory airway disease. We evaluated secondary safety outcomes in a comparative effectiveness study of chronic inhaled corticosteroids (ICS) and macrolide monotherapy in bronchiectasis patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective study using US Medicare Parts A, B and D (but not C) 2006\u20132014 datasets. Among those with a pulmonologist-associated bronchiectasis claim (ICD-9-CM 494.0 or 494.1), without cystic fibrosis, we identified the first new use of either chronic (&gt;28\u2005days) ICS or macrolide monotherapy. For each drug exposure, we calculated crude incidence rates of the secondary safety outcomes: arrhythmia, myocardial infarction, sensorineural hearing loss, hip fracture and opportunistic infections. We calculated a propensity score (PS) for ICS use using demographic, clinical and utilisation characteristics and compared risks of macrolides<jats:italic>versus<\/jats:italic>ICS for each outcome using PS decile-adjusted Cox regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 285\u200a043 Medicare patients with bronchiectasis, we identified 6500 (2%) macrolide and 83\u200a589 (29%) ICS new users. Key covariates were balanced across exposure groups within decile. Myocardial infarction, hip fracture and opportunistic infection were not significantly associated with treatment. Macrolides were associated with a decreased risk of arrhythmia (adjusted hazard ratio (aHR) 0.87, 95% CI 0.80\u20130.94) and an increased risk of sensorineural hearing loss (aHR 1.38, 95% CI 1.56\u20131.22) compared to ICS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Macrolides were not associated with an elevated risk of acute cardiac events compared to ICS. The increased risk of hearing loss in macrolide users compared to ICS users in older bronchiectasis patients should be balanced against known benefits of macrolides.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00786-2020","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T17:40:13Z","timestamp":1644601213000},"page":"00786-2020","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis"],"prefix":"10.1183","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-9383","authenticated-orcid":false,"given":"Emily","family":"Henkle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Aksamit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"2024101711293784000_8.1.00786-2020.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136119"},{"key":"2024101711293784000_8.1.00786-2020.2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbr.2017.07.014","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Martinez-Garcia","year":"2018","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"2024101711293784000_8.1.00786-2020.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024101711293784000_8.1.00786-2020.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1937"},{"key":"2024101711293784000_8.1.00786-2020.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60953-2"},{"key":"2024101711293784000_8.1.00786-2020.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2290"},{"key":"2024101711293784000_8.1.00786-2020.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003833"},{"key":"2024101711293784000_8.1.00786-2020.8","first-page":"523","article-title":"Drug induced QT prolongation","volume":"14","author":"Zareba","year":"2007","journal-title":"Cardiol J"},{"key":"2024101711293784000_8.1.00786-2020.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.029"},{"key":"2024101711293784000_8.1.00786-2020.10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00438-18"},{"key":"2024101711293784000_8.1.00786-2020.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.09.009"},{"key":"2024101711293784000_8.1.00786-2020.12","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0533-2"},{"key":"2024101711293784000_8.1.00786-2020.13","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201307-231OC"},{"key":"2024101711293784000_8.1.00786-2020.14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/lary.26799","article-title":"Macrolide-associated sensorineural hearing loss: a systematic review","volume":"128","author":"Ikeda","year":"2018","journal-title":"Laryngoscope"},{"key":"2024101711293784000_8.1.00786-2020.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01896-2018"},{"key":"2024101711293784000_8.1.00786-2020.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.21705"},{"key":"2024101711293784000_8.1.00786-2020.17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00198-003-1398-z","article-title":"Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review","volume":"14","author":"Richy","year":"2003","journal-title":"Osteoporos Int"},{"key":"2024101711293784000_8.1.00786-2020.18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.12.1383"},{"key":"2024101711293784000_8.1.00786-2020.19","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.chest.2017.04.167","article-title":"Pharmacotherapy for non-cystic fibrosis bronchiectasis: results from an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry","volume":"152","author":"Henkle","year":"2017","journal-title":"Chest"},{"key":"2024101711293784000_8.1.00786-2020.20","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg231"},{"key":"2024101711293784000_8.1.00786-2020.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"2024101711293784000_8.1.00786-2020.22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192704"},{"key":"2024101711293784000_8.1.00786-2020.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300799"},{"key":"2024101711293784000_8.1.00786-2020.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.4304"},{"key":"2024101711293784000_8.1.00786-2020.25","doi-asserted-by":"crossref","first-page":"e208199","DOI":"10.1001\/jamanetworkopen.2020.8199","article-title":"Association of azithromycin use with cardiovascular mortality","volume":"3","author":"Zaroff","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024101711293784000_8.1.00786-2020.26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008074"},{"key":"2024101711293784000_8.1.00786-2020.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104623"},{"key":"2024101711293784000_8.1.00786-2020.28","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310897"},{"key":"2024101711293784000_8.1.00786-2020.29","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150901"},{"key":"2024101711293784000_8.1.00786-2020.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510350050036"},{"key":"2024101711293784000_8.1.00786-2020.31","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.1016"},{"key":"2024101711293784000_8.1.00786-2020.32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201402-0385CI"},{"key":"2024101711293784000_8.1.00786-2020.33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MCP.0000000000000554","article-title":"Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease: current understanding and recommendations","volume":"25","author":"Moon","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"2024101711293784000_8.1.00786-2020.34","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/crj.12744","article-title":"Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: a propensity score matched study","volume":"12","author":"Tsai","year":"2018","journal-title":"Clin Respir J"},{"key":"2024101711293784000_8.1.00786-2020.35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.chest.2017.07.002","article-title":"Long-term use of inhaled corticosteroids in COPD and the risk of fracture","volume":"153","author":"Gonzalez","year":"2018","journal-title":"Chest"},{"key":"2024101711293784000_8.1.00786-2020.36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203407"},{"key":"2024101711293784000_8.1.00786-2020.37","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.amepre.2016.08.029","article-title":"Herpes zoster vaccine coverage in older adults in the U.S., 2007\u20132013","volume":"52","author":"Zhang","year":"2017","journal-title":"Am J Prev Med"},{"key":"2024101711293784000_8.1.00786-2020.38","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.958"},{"key":"2024101711293784000_8.1.00786-2020.39","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.5.983"},{"key":"2024101711293784000_8.1.00786-2020.40","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.30"},{"key":"2024101711293784000_8.1.00786-2020.41","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3334"},{"key":"2024101711293784000_8.1.00786-2020.42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"2024101711293784000_8.1.00786-2020.43","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.chest.2018.07.014","article-title":"Characteristics and health-care utilization history of patients with bronchiectasis in US Medicare enrollees with prescription drug plans, 2006 to 2014","volume":"154","author":"Henkle","year":"2018","journal-title":"Chest"},{"issue":"Suppl. 1","key":"2024101711293784000_8.1.00786-2020.44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/pds.2340","article-title":"A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data","volume":"21","author":"Tamariz","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024101711293784000_8.1.00786-2020.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.02.013"},{"key":"2024101711293784000_8.1.00786-2020.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2011.09.001"},{"key":"2024101711293784000_8.1.00786-2020.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.07.011"},{"key":"2024101711293784000_8.1.00786-2020.48","doi-asserted-by":"publisher","DOI":"10.1086\/430325"},{"key":"2024101711293784000_8.1.00786-2020.49","doi-asserted-by":"publisher","DOI":"10.1017\/S095026880400281X"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00786-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:14:07Z","timestamp":1740374047000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00786-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,7]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1183\/23120541.00786-2020"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00786-2020","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}